Menu
Commercial APIs
| S.No. | Product | CAS No. | Pharmacopeia | Therapeutic Use | DMF | COS |
|---|---|---|---|---|---|---|
| 1 | 72956–09-3 | In-house/IP/BP/Ph.Eur/USP/JP | Anti-Hypertensive | ✓ | ✓ | |
| 2 | 59729-32-7 | In-house/IP/BP/Ph.Eur/USP | Anti-Depressant | ✓ | ✓ | |
| 3 | 136434-34-9 | In-house/IP/Ph.Eur/USP | Anti-Depressant | ✓ | ✓ | |
| 4 | 219861-08-2 | In-house/IP/Ph.Eur/USP | Anti-Depressant | ✓ | ✓ | |
| 5 | 99614-02-5 | In-house/IP/USP | Anti-Emetic | ✓ | ||
| 6 | 103639-04-9 | In-house/IP/BP/Ph.Eur/USP | Anti-Emetic | ✓ | ✓ | |
| 7 | 123441-03-2 | In-house/Ph.Eur/USP | Alzheimer’s | ✓ | ✓ | |
| 8 | 129101-54-8 | In-house/Ph.Eur/USP | Alzheimer’s | ✓ | ✓ | |
| 9 | 108612-45-9 | In-house | Anti-Histamine | ✓ | ||
| 10 | Carbidopa | 28860-95-9 | In-house/IP/BP/Ph.Eur/USP | Anti-Parkinson | ✓ | |
| 11 | Fluindione | 957-56-2 | In-house | Vit-K Antagonist | ✓ | |
| 12 | 97240-79-4 | IP/USP | Epilepsy | ✓ | ||
| 13 | 122883-93-6 | USP/Ph.Eur | Anti-Psychotic | ✓ | ||
| 14 | 124937-52-6 | In-house/IP/USP | Overactive Bladder | Tech. pack | ||
| 15 | Desvenlafaxine Succinate | 448904-47-0 | In-house/USP | Anti-Depressant | Tech. pack |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S.No. | Product | CAS No. | Pharmacopeia | Therapeutic Use | DMF | COS |
|---|---|---|---|---|---|---|
| 1 | 72956–09-3 | In-house/IP/BP/Ph.Eur/USP/JP | Anti-Hypertensive | ✓ | ✓ | |
| 2 | 59729-32-7 | In-house/IP/BP/Ph.Eur/USP | Anti-Depressant | ✓ | ✓ | |
| 3 | 136434-34-9 | In-house/IP/Ph.Eur/USP | Anti-Depressant | ✓ | ✓ | |
| 4 | 219861-08-2 | In-house/IP/Ph.Eur/USP | Anti-Depressant | ✓ | ✓ | |
| 5 | 99614-02-5 | In-house/IP/USP | Anti-Emetic | ✓ | ✓ | |
| 6 | 103639-04-9 | In-house/IP/BP/Ph.Eur/USP | Anti-Emetic | ✓ | ✓ | |
| 7 | 123441-03-2 | In-house/Ph.Eur/USP | Alzheimer’s | ✓ | ✓ | |
| 8 | 129101-54-8 | In-house/Ph.Eur/USP | Alzheimer’s | ✓ | ✓ | |
| 9 | 108612-45-9 | In-house | Anti-Histamine | ✓ | ||
| 10 | Carbidopa | 28860-95-9 | In-house/IP/BP/Ph.Eur/USP | Anti-Parkinson | ✓ | |
| 11 | Fluindione | 957-56-2 | In-house | Vit-K Antagonist | ✓ | |
| 12 | Topiramate | 97240-79-4 | IP/USP | Epilepsy | ✓ | |
| 13 | Ziprasidone Hydrochloride | 122883-93-6 | USP/Ph.Eur | Anti-Psychotic | ✓ | |
| 14 | Tolterodine Tartrate | 124937-52-6 | In-house/IP/USP | Overactive Bladder | Tech. pack | |
| 15 | Desvenlafaxine Succinate | 448904-47-0 | In-house/USP | Anti-Depressant | Tech. pack |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
